+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Breast Biopsy Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 187 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6083426
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The breast biopsy market is evolving rapidly, shaped by growing clinical demand for precision, operational efficiency, and the shift toward patient-centric care. Strategic decisions increasingly rely on advanced technologies, seamless workflow integration, and robust procurement models.

Market Snapshot: Breast Biopsy Market Growth

The Breast Biopsy Market grew from USD 1.90 billion in 2024 to USD 2.02 billion in 2025 and is projected to reach USD 3.17 billion by 2032, reflecting a compound annual growth rate (CAGR) of 6.63%. Rising adoption of sophisticated imaging and automation technologies, combined with increasing outpatient procedure volumes, is driving sustained market expansion.

Scope & Segmentation

  • Device Technologies: Core needle biopsy devices (automated and semi-automated), fine needle aspiration needles (including echo enhanced and standard), and vacuum-assisted biopsy systems (handheld and table-based)
  • Procedural Approaches: Ultrasound-guided (2D and 3D), MRI-guided (open and closed bore), stereotactic (prone and upright), and palpation-guided techniques (freehand and grid based)
  • Care Settings: Ambulatory surgery centers, hospitals, and specialty clinics (oncology and radiology)
  • Geographic Regions: Americas, Europe, Middle East & Africa, Asia-Pacific
  • Stakeholder Groups: Radiologists, oncologists, pathology labs, health system procurement teams, supply chain partners, device manufacturers, and payers

Key Takeaways for Senior Decision-Makers

  • Convergence of imaging advances and device ergonomics is enhancing diagnostic accuracy and increasing accessibility in outpatient settings.
  • Procurement trends emphasize total cost of ownership, driving demand for service contracts, consumables management, and bundled procurement models.
  • Vacuum-assisted and automated solutions are redefining procedural algorithms, enabling broader adoption and efficient workflow integration.
  • Regional dynamics shape adoption; the Americas favor outpatient models and efficient workflows, while Europe, Middle East & Africa, and Asia-Pacific exhibit varied regulatory pathways and cost sensitivities.
  • Manufacturers are pursuing interoperability, supply chain resilience, and flexible commercial models to meet evolving buyer criteria and mitigate supply risks.

Tariff Impact and Supply Chain Strategies

Tariff shifts in 2025 have altered breast biopsy value chains, impacting component sourcing, pricing, and supplier strategy. Device manufacturers are responding with nearshoring and expanded supplier qualification to minimize tariff exposure. Procurement teams increasingly assess long-term agreements and total cost metrics, moving beyond upfront pricing. Supply chain partners are focusing on contractual flexibility and inventory resilience, ensuring stable procedural access for providers.

Primary Keyword in Context: Breast Biopsy Market

In the breast biopsy market, technology innovation, integrated care models, and commercial adaptability are crucial for sustained adoption. Clinicians seek devices that reduce sampling error and facilitate faster diagnostic pathways, while administrators prioritize throughput, integration, and predictable operating costs in their procurement decisions.

Methodology & Data Sources

This analysis is based on structured interviews with clinicians, supply chain leaders, and administrators, direct procedural observations, and a review of clinical research, regulatory documentation, and procurement guidelines. Primary findings were validated through expert panels and scenario testing, ensuring data reliability and actionable insight.

Why This Report Matters

  • Enables informed strategic planning for stakeholders seeking to align technology investments with emerging clinical and operational priorities.
  • Supports procurement leaders and manufacturers with actionable insight into regional adoption patterns, supply chain risks, and evolving care model requirements.
  • Offers clarity on competitive positioning and future-proofing investments amidst shifting regulatory and tariff landscapes.

Conclusion

The future of the breast biopsy sector will be determined by the ability to integrate clinical innovation, operational efficiency, and robust supply chain strategies. Stakeholders able to demonstrate measurable outcomes and adaptable models will secure lasting market advantage.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2024
3.5. FPNV Positioning Matrix, 2024
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Breast Biopsy Market, by Product Type
8.1. Biopsy Needles
8.2. Guidance Systems
8.3. Biopsy Guns
8.4. Consumables & Accessories
9. Breast Biopsy Market, by Procedure Type
9.1. Core Needle Biopsy
9.2. Vacuum-Assisted Biopsy
9.3. Fine Needle Aspiration Biopsy
9.4. Surgical/Open Biopsy
9.4.1. Excisional Biopsy
9.4.2. Incisional Biopsy
10. Breast Biopsy Market, by Guidance Modality
10.1. Ultrasound-Guided Biopsy
10.2. Stereotactic X-Ray-Guided Biopsy
10.3. MRI-Guided Biopsy
11. Breast Biopsy Market, by Biopsy Site
11.1. Breast Parenchyma
11.2. Axillary & Regional Lymph Nodes
11.3. Nipple & Ductal Structures
12. Breast Biopsy Market, by End User
12.1. Ambulatory Surgery Centers
12.2. Hospitals
12.3. Specialty Clinics
13. Breast Biopsy Market, by Clinical Indication
13.1. Early Cancer Screening
13.2. Therapy Selection
13.3. Recurrence & Treatment Monitoring
14. Breast Biopsy Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Breast Biopsy Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Breast Biopsy Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Breast Biopsy Market
18. China Breast Biopsy Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2024
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2024
19.3. Product Portfolio Analysis, 2024
19.4. Benchmarking Analysis, 2024
19.5. Argon Medical Devices, Inc.
19.6. Becton Dickinson and Company
19.7. Cook Group Incorporated
19.8. Danaher Corporation
19.9. Exact Sciences Corporation
19.10. FUJIFILM Corporation
19.11. GE HealthCare
19.12. Hologic, Inc.
19.13. Medtronic PLC
19.14. Merit Medical Systems, Inc.
19.15. Siemens Healthineers AG
19.16. Sysmex Corporation
List of Figures
FIGURE 1. GLOBAL BREAST BIOPSY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BREAST BIOPSY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 3. GLOBAL BREAST BIOPSY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 4. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE MODALITY, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY SITE, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BREAST BIOPSY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BREAST BIOPSY MARKET SIZE, BY CLINICAL INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BREAST BIOPSY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL BREAST BIOPSY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES BREAST BIOPSY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA BREAST BIOPSY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BREAST BIOPSY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY GUNS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY GUNS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY GUNS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BREAST BIOPSY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BREAST BIOPSY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BREAST BIOPSY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED BIOPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION BIOPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BREAST BIOPSY MARKET SIZE, BY SURGICAL/OPEN BIOPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BREAST BIOPSY MARKET SIZE, BY SURGICAL/OPEN BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BREAST BIOPSY MARKET SIZE, BY SURGICAL/OPEN BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BREAST BIOPSY MARKET SIZE, BY SURGICAL/OPEN BIOPSY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BREAST BIOPSY MARKET SIZE, BY EXCISIONAL BIOPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BREAST BIOPSY MARKET SIZE, BY EXCISIONAL BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BREAST BIOPSY MARKET SIZE, BY EXCISIONAL BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BREAST BIOPSY MARKET SIZE, BY INCISIONAL BIOPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BREAST BIOPSY MARKET SIZE, BY INCISIONAL BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BREAST BIOPSY MARKET SIZE, BY INCISIONAL BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE MODALITY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC X-RAY-GUIDED BIOPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC X-RAY-GUIDED BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC X-RAY-GUIDED BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI-GUIDED BIOPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI-GUIDED BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI-GUIDED BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY SITE, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BREAST BIOPSY MARKET SIZE, BY BREAST PARENCHYMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BREAST BIOPSY MARKET SIZE, BY BREAST PARENCHYMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BREAST BIOPSY MARKET SIZE, BY BREAST PARENCHYMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BREAST BIOPSY MARKET SIZE, BY AXILLARY & REGIONAL LYMPH NODES, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BREAST BIOPSY MARKET SIZE, BY AXILLARY & REGIONAL LYMPH NODES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BREAST BIOPSY MARKET SIZE, BY AXILLARY & REGIONAL LYMPH NODES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BREAST BIOPSY MARKET SIZE, BY NIPPLE & DUCTAL STRUCTURES, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BREAST BIOPSY MARKET SIZE, BY NIPPLE & DUCTAL STRUCTURES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BREAST BIOPSY MARKET SIZE, BY NIPPLE & DUCTAL STRUCTURES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BREAST BIOPSY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BREAST BIOPSY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BREAST BIOPSY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BREAST BIOPSY MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BREAST BIOPSY MARKET SIZE, BY EARLY CANCER SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BREAST BIOPSY MARKET SIZE, BY EARLY CANCER SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BREAST BIOPSY MARKET SIZE, BY EARLY CANCER SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BREAST BIOPSY MARKET SIZE, BY THERAPY SELECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BREAST BIOPSY MARKET SIZE, BY THERAPY SELECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BREAST BIOPSY MARKET SIZE, BY THERAPY SELECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BREAST BIOPSY MARKET SIZE, BY RECURRENCE & TREATMENT MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BREAST BIOPSY MARKET SIZE, BY RECURRENCE & TREATMENT MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BREAST BIOPSY MARKET SIZE, BY RECURRENCE & TREATMENT MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BREAST BIOPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS BREAST BIOPSY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS BREAST BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS BREAST BIOPSY MARKET SIZE, BY SURGICAL/OPEN BIOPSY, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS BREAST BIOPSY MARKET SIZE, BY GUIDANCE MODALITY, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS BREAST BIOPSY MARKET SIZE, BY BIOPSY SITE, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS BREAST BIOPSY MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 86. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY SURGICAL/OPEN BIOPSY, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY GUIDANCE MODALITY, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY BIOPSY SITE, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 94. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY SURGICAL/OPEN BIOPSY, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY GUIDANCE MODALITY, 2018-2032 (USD MILLION)
TABLE 97. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY BIOPSY SITE, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY SURGICAL/OPEN BIOPSY, 2018-2032 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY GUIDANCE MODALITY, 2018-2032 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY BIOPSY SITE, 2018-2032 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
TABLE 108. EUROPE BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. EUROPE BREAST BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 110. EUROPE BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 111. EUROPE BREAST BIOPSY MARKET SIZE, BY SURGICAL/OPEN BIOPSY, 2018-2032 (USD MILLION)
TABLE 112. EUROPE BREAST BIOPSY MARKET SIZE, BY GUIDANCE MODALITY, 2018-2032 (USD MILLION)
TABLE 113. EUROPE BREAST BIOPSY MARKET SIZE, BY BIOPSY SITE, 2018-2032 (USD MILLION)
TABLE 114. EUROPE BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 115. EUROPE BREAST BIOPSY MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST BREAST BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST BREAST BIOPSY MARKET SIZE, BY SURGICAL/OPEN BIOPSY, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST BREAST BIOPSY MARKET SIZE, BY GUIDANCE MODALITY, 2018-2032 (USD MILLION)
TABLE 121. MIDDLE EAST BREAST BIOPSY MARKET SIZE, BY BIOPSY SITE, 2018-2032 (USD MILLION)
TABLE 122. MIDDLE EAST BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 123. MIDDLE EAST BREAST BIOPSY MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
TABLE 124. AFRICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. AFRICA BREAST BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 126. AFRICA BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 127. AFRICA BREAST BIOPSY MARKET SIZE, BY SURGICAL/OPEN BIOPSY, 2018-2032 (USD MILLION)
TABLE 128. AFRICA BREAST BIOPSY MARKET SIZE, BY GUIDANCE MODALITY, 2018-2032 (USD MILLION)
TABLE 129. AFRICA BREAST BIOPSY MARKET SIZE, BY BIOPSY SITE, 2018-2032 (USD MILLION)
TABLE 130. AFRICA BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. AFRICA BREAST BIOPSY MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY SURGICAL/OPEN BIOPSY, 2018-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY GUIDANCE MODALITY, 2018-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY BIOPSY SITE, 2018-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL BREAST BIOPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. ASEAN BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. ASEAN BREAST BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 143. ASEAN BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 144. ASEAN BREAST BIOPSY MARKET SIZE, BY SURGICAL/OPEN BIOPSY, 2018-2032 (USD MILLION)
TABLE 145. ASEAN BREAST BIOPSY MARKET SIZE, BY GUIDANCE MODALITY, 2018-2032 (USD MILLION)
TABLE 146. ASEAN BREAST BIOPSY MARKET SIZE, BY BIOPSY SITE, 2018-2032 (USD MILLION)
TABLE 147. ASEAN BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. ASEAN BREAST BIOPSY MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
TABLE 149. GCC BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. GCC BREAST BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 151. GCC BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 152. GCC BREAST BIOPSY MARKET SIZE, BY SURGICAL/OPEN BIOPSY, 2018-2032 (USD MILLION)
TABLE 153. GCC BREAST BIOPSY MARKET SIZE, BY GUIDANCE MODALITY, 2018-2032 (USD MILLION)
TABLE 154. GCC BREAST BIOPSY MARKET SIZE, BY BIOPSY SITE, 2018-2032 (USD MILLION)
TABLE 155. GCC BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. GCC BREAST BIOPSY MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION BREAST BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 160. EUROPEAN UNION BREAST BIOPSY MARKET SIZE, BY SURGICAL/OPEN BIOPSY, 2018-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION BREAST BIOPSY MARKET SIZE, BY GUIDANCE MODALITY, 2018-2032 (USD MILLION)
TABLE 162. EUROPEAN UNION BREAST BIOPSY MARKET SIZE, BY BIOPSY SITE, 2018-2032 (USD MILLION)
TABLE 163. EUROPEAN UNION BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 164. EUROPEAN UNION BREAST BIOPSY MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
TABLE 165. BRICS BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. BRICS BREAST BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 167. BRICS BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 168. BRICS BREAST BIOPSY MARKET SIZE, BY SURGICAL/OPEN BIOPSY, 2018-2032 (USD MILLION)
TABLE 169. BRICS BREAST BIOPSY MARKET SIZE, BY GUIDANCE MODALITY, 2018-2032 (USD MILLION)
TABLE 170. BRICS BREAST BIOPSY MARKET SIZE, BY BIOPSY SITE, 2018-2032 (USD MILLION)
TABLE 171. BRICS BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 172. BRICS BREAST BIOPSY MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
TABLE 173. G7 BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. G7 BREAST BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 175. G7 BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 176. G7 BREAST BIOPSY MARKET SIZE, BY SURGICAL/OPEN BIOPSY, 2018-2032 (USD MILLION)
TABLE 177. G7 BREAST BIOPSY MARKET SIZE, BY GUIDANCE MODALITY, 2018-2032 (USD MILLION)
TABLE 178. G7 BREAST BIOPSY MARKET SIZE, BY BIOPSY SITE, 2018-2032 (USD MILLION)
TABLE 179. G7 BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. G7 BREAST BIOPSY MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
TABLE 181. NATO BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 182. NATO BREAST BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 183. NATO BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 184. NATO BREAST BIOPSY MARKET SIZE, BY SURGICAL/OPEN BIOPSY, 2018-2032 (USD MILLION)
TABLE 185. NATO BREAST BIOPSY MARKET SIZE, BY GUIDANCE MODALITY, 2018-2032 (USD MILLION)
TABLE 186. NATO BREAST BIOPSY MARKET SIZE, BY BIOPSY SITE, 2018-2032 (USD MILLION)
TABLE 187. NATO BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 188. NATO BREAST BIOPSY MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. UNITED STATES BREAST BIOPSY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 191. UNITED STATES BREAST BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 192. UNITED STATES BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 193. UNITED STATES BREAST BIOPSY MARKET SIZE, BY SURGICAL/OPEN BIOPSY, 2018-2032 (USD MILLION)
TABLE 194. UNITED STATES BREAST BIOPSY MARKET SIZE, BY GUIDANCE MODALITY, 2018-2032 (USD MILLION)
TABLE 195. UNITED STATES BREAST BIOPSY MARKET SIZE, BY BIOPSY SITE, 2018-2032 (USD MILLION)
TABLE 196. UNITED STATES BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 197. UNITED STATES BREAST BIOPSY MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
TABLE 198. CHINA BREAST BIOPSY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 199. CHINA BREAST BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 200. CHINA BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 201. CHINA BREAST BIOPSY MARKET SIZE, BY SURGICAL/OPEN BIOPSY, 2018-2032 (USD MILLION)
TABLE 202. CHINA BREAST BIOPSY MARKET SIZE, BY GUIDANCE MODALITY, 2018-2032 (USD MILLION)
TABLE 203. CHINA BREAST BIOPSY MARKET SIZE, BY BIOPSY SITE, 2018-2032 (USD MILLION)
TABLE 204. CHINA BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 205. CHINA BREAST BIOPSY MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Breast Biopsy market report include:
  • A.Menarini Industrie Farmaceutiche Riunite S.r.l.
  • Argon Medical Devices, Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc
  • Canon Medical Systems Corporation
  • Cook Group Incorporated
  • CooperSurgical, Inc.
  • Danaher Corporation
  • Exact Sciences Corporation
  • FUJIFILM Corporation
  • GE HealthCare
  • Guardant Health, Inc.
  • Halma PLC
  • Hologic, Inc.
  • INRAD, Inc.
  • Johnson & Johnson
  • Koninklijke Philips N.V.
  • Medax Srl Unipersonale
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Planmed Oy
  • QIAGEN N.V.
  • Resitu Medical AB
  • Siemens Healthineers AG
  • STERYLAB S.r.l.
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • TransMed7, LLC
  • Trivitron Healthcare

Table Information